These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 2290463)
41. Evaluation of KIR4.1 as an Immune Target in Multiple Sclerosis. Chastre A; Hafler DA; O'Connor KC N Engl J Med; 2016 Apr; 374(15):1495-6. PubMed ID: 27074083 [No Abstract] [Full Text] [Related]
42. Antibodies to potassium channels in multiple sclerosis. Cross AH; Waubant E N Engl J Med; 2012 Jul; 367(2):172-4. PubMed ID: 22784120 [No Abstract] [Full Text] [Related]
43. Autoantibodies in serum and CSF of patients with multiple sclerosis. Blancher A; Matsiota P; Guilbert B; Doyon B; Clanet M; Kouvelas E; Rascol A; Avrameas S Ann N Y Acad Sci; 1988; 540():290-2. PubMed ID: 3207257 [No Abstract] [Full Text] [Related]
44. Metalloproteinases and specific inhibitors in multiple sclerosis: from blood to brain or vice versa? Opdenakker G Brain; 1999 Feb; 122 ( Pt 2)():181-2. PubMed ID: 10071046 [No Abstract] [Full Text] [Related]
45. Autoantibodies against pituitary peptides in sera from patients with multiple sclerosis. Langvad B; Jans H; Heltberg A; Hansen GN Acta Neurol Scand; 1986 Jan; 73(1):79. PubMed ID: 3953263 [No Abstract] [Full Text] [Related]
46. In vitro toxicity of MS sera correlates with new clinical signs. Bradbury K; Aparicio SR; Sumner DW; MacFie A; Bird CC Acta Neurol Scand; 1984 Dec; 70(6):456-9. PubMed ID: 6516796 [TBL] [Abstract][Full Text] [Related]
47. Synthesis of organometallic glycopeptides and electrochemical studies to detect autoantibodies in multiple sclerosis patients' sera. Real-Fernández F; Chamois-Colson A; Bayardon J; Nuti F; Peroni E; Moncelli MR; Meunier-Prest R; Jugè S; Papini AM Adv Exp Med Biol; 2009; 611():435-6. PubMed ID: 19400254 [No Abstract] [Full Text] [Related]